Boston Scientific Corp.

( )
BSX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
DHRDanaher Corp. 1.10%305.660.7%$613.02m
TMOThermo Fisher Scientific, Inc. 0.28%538.501.0%$611.35m
ABTAbbott Laboratories -0.41%121.620.8%$552.52m
ISRGIntuitive Surgical, Inc. -0.87%990.882.3%$456.67m
MDTMedtronic Plc -2.30%128.440.6%$445.52m
ALGNAlign Technology, Inc. 0.95%708.016.3%$440.86m
DXCMDexCom, Inc. -1.28%514.537.8%$351.17m
SYKStryker Corp. -2.02%262.611.3%$312.50m
BSXBoston Scientific Corp. -2.75%44.291.0%$293.47m
NURONeuroMetrix, Inc. -8.80%13.267.7%$289.19m
AAgilent Technologies, Inc. 0.21%154.181.6%$283.92m
EWEdwards Lifesciences Corp. -0.26%114.400.4%$280.33m
IDXXIDEXX Laboratories, Inc. 0.40%698.483.8%$262.45m
BDXBecton, Dickinson & Co. -0.35%254.881.0%$248.05m
BAXBaxter International, Inc. -1.48%75.151.8%$220.57m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.